ChemBio Annouces the Collaboration with FIND Moving to Development of HCV Point-Of-Care Diagnostic-Test
ChemBio Annouces the Collaboration with FIND Moving to Development of HCV Point-Of-Care Diagnostic-Test
Shots:
- ChemBio will be using its patented DPP® technology platform to test rapid HCV core antigen assay
- Parallely, FIND is conducting pilot studies in six countries to introduce novel algorithms and demonstrate the impact of HCV rapid diagnostics
- FIND plans to assess the outcomes of the feasibility studies in Dec’18 and fund one company for further development and validation of the HCV core antigen assay
- As per WHO, ~71Mn people are suffering from HCV infection with nearly 400,00 deaths/yr
Click here to read full press release/ article | Ref: Chembio Diagnostics | Image: ChemBio